Suppressor and Cytolytic Cell Function in Multiple Sclerosis. Effects of Cyclosporine a and Interleukin 2.

Journal of Clinical Investigation - United States
doi 10.1172/jci112612
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Dimethyl Fumarate Treatment Alters NK Cell Function in Multiple Sclerosis

European Journal of Immunology
AllergyImmunology
2017English

Interleukin 2 Promotes Growth and Cytolytic Activity in Human T3+4-8- Thymocytes.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Inhibition of Calcineurin by Cyclosporine a Exerts Multiple Effects on Human Melanoma Cell Lines HT168 and WM35

International Journal of Oncology
Cancer ResearchOncology
2009English

Interleukin-22 Is Increased in Multiple Sclerosis Patients and Targets Astrocytes

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2015English

Interleukin-17—Extended Features of a Key Player in Multiple Sclerosis

American Journal of Pathology
Forensic MedicinePathology
2008English

Restoring Function in Progressive Multiple Sclerosis

The Lancet Neurology
Neurology
2019English

Promoting Myelin Repair and Return of Function in Multiple Sclerosis

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2011English

Respiratory Muscle Function and Exercise Capacity in Multiple Sclerosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1994English

Effects of Interleukin-2 in Immunostimulation and Immunosuppression

Journal of Experimental Medicine
MedicineAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy